LB1702 Lebrikizumab does not impact vaccine-induced immune responses: Results from a phase 3 study in adult patients with moderate-to-severe atopic dermatitis

Saved in:
Bibliographic Details
Published inJournal of investigative dermatology Vol. 143; no. 9; p. B15
Main Authors Soung, J., Laquer, V., Merola, J.F., Forman, S., Elmaraghy, H., Meskimen, E., Hu, C., Natalie, C., Pierce, E., Torisu-Itakura, H., Gil, E., Jarell, A.
Format Journal Article
LanguageEnglish
Published 01.09.2023
Online AccessGet full text

Cover

More Information
ISSN:0022-202X
DOI:10.1016/j.jid.2023.06.076